SHP625

The top 10 biopharma pipeline disasters of 2015
Fierce Biotech
Fri, 10/30/15 - 09:55 am
Eli Lilly
GSK
AstraZeneca
Shire
Celladon
Takeda
Merck
Roche
Verastem
evacetrapib
Breo Ellipta
brodalumab
selumetinib
SHP625
Mydicar
Alisertib
suggammadex
sembragiline
Defactinib
One of Shire's top blockbuster drug prospects flops in a key PhII study
Fierce Biotech
Thu, 04/9/15 - 09:22 am
Shire
SHP625
Lumena Pharmaceuticals